Enroll in our Schizophrenia Clinical Research Trials
Does your child have
CMB Clinical Trials is currently enrolling patients, aged 13 to 18, with schizophrenia for a clinical research study of an investigational drug.
If you or someone you know suffers from Schizophrenia, fill out the form and help in advancement of medicine.
Adolescent Schizophrenia is a severe mental health disorder, impacting a person’s ability to distinguish the imaginary from the reality. Characterized by hallucinations, delusions, and disorganized behavior, the disorder can be attributed to several causes, including genetic causes, behavioral and environmental factors, etc. Early warning signs of schizophrenia in kids and adolescents include visual and auditory hallucinations, delusions, disorganized speech and behavior, flat affect, social withdrawal, paranoia, etc.
Why does schizophrenia begin in adolescence?
The manifestation of schizophrenia symptoms before the age of 12 is infrequent. However, the symptoms in adolescents are similar to the symptoms in adults. Generally, the symptoms start manifesting in young adults, but it can also develop earlier due to some neurodevelopmental risk factors. These risk factors include genetic disorders, childhood brain injury, exposure to certain substances and drugs, undernutrition, a family history of the disorder, chemical imbalance in the brain, etc.
Treatment of schizophrenia in adolescents
Recent researches reveal that increased use of cannabis products containing tetrahydrocannabinol (THC) increases the risk of developing psychotic disorders, including schizophrenia and bipolar disorder. Treatment of schizophrenia in adolescents can be a complicated process, depending on various factors, including the combination of drugs and therapies prescribed, age of the adolescents, medical history, severity of the condition, type of schizophrenia, etc. However, these are not the only methods for treating the disorder.
Participation in adolescent schizophrenia clinical trials has become an effective way for adolescents with schizophrenia to treat the disorder. CMB Clinical Trials are actively looking for Schizophrenia clinical trial participants to test the efficacy of investigational schizophrenia medications. If you are an adolescent with schizophrenia, fill the form to participate in our clinical trials for schizophrenia in teens.
Key Facts about our Schizophrenia Trials
Length of Trial
Qualifying participants will be compensated for their travel expenses starting 100 USD.
Schizophrenia in US
Risk of developing Schizophrenia
Statistics show that schizophrenia affects approximately 1% (2.4 million) Americans. Schizophrenia in children under the age of 12 is uncommon and hard to identify in the early phases. However, children as young as five can develop schizophrenia symptoms in infrequent instances. Children's risk of developing schizophrenia can depend on whether their family members have the disorder. The risk for adolescents developing schizophrenia is 10% if their parents are diagnosed with the disorder.
Follow CMB Clinical Trials to keep updated on how to take care of your mental health.